drugset / Trial / NCT02565862

A Drug-drug Interaction Study Between Daclatasvir and Metformin

NCT02565862

Phase 1 Completed 20 enrolled Radboud University Medical Center
RandomizedCrossoverOpen-labelOther

Summary

This study aims to provide clinical information on a potential drug-drug interaction between daclatasvir and metformin.

Timeline

Start
2016-01
Primary completion
2016-03
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Daclatasvir Small molecule 60 mg
Subject Metformin Small molecule 1000 mg